Home >> MARKETPLACE >> Beckman files 510(k) for Early Sepsis Indicator

Beckman files 510(k) for Early Sepsis Indicator

Print Friendly, PDF & Email

October 2018—Beckman Coulter filed a submission for 510(k) clearance with the FDA for its Early Sepsis Indicator, offered as part of a standard CBC with differential test. As such, test results can be available in less than one hour. The Early Sepsis Indicator, which recently achieved CE marking, is available in select countries for use with the company’s DxH 900 hematology analyzer.

Beckman Coulter, 714-993-5321

x

Check Also

Beckman Coulter, Arkray launch iQ Workcell

Aug. 1, 2018—Beckman Coulter and U.S. Arkray announced a partnership and the launch of the...

X